With this approval, pediatric patients aged five years and older with active lupus nephritis will...
The Canada Disability Benefit (CDB) is an important step forward to improving Canada’s social safety...
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA)...
Lupus Ontario is excited to share share positive news of the Phase 3 REGENCY clinical...
Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people...
Living with lupus means constantly adjusting to the fluctuating demands of your health, your career,...
In 2023, Vanessa Cava and Abbey Hunter organized the Thunder Bay WALK for Lupus Ontario....
